M. Mitchard

1.1k total citations
57 papers, 884 citations indexed

About

M. Mitchard is a scholar working on Pharmacology, Molecular Biology and Spectroscopy. According to data from OpenAlex, M. Mitchard has authored 57 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Spectroscopy. Recurrent topics in M. Mitchard's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Analytical Methods in Pharmaceuticals (9 papers) and Analytical Chemistry and Chromatography (8 papers). M. Mitchard is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Analytical Methods in Pharmaceuticals (9 papers) and Analytical Chemistry and Chromatography (8 papers). M. Mitchard collaborates with scholars based in United Kingdom, Cameroon and Sweden. M. Mitchard's co-authors include M. J. Kendall, A H Beckett, V. Rovei, P. L. Morselli, J. W. CLITHEROW, N. Harper, Roberto Goméni, J. Salmon, Kelvin Chan and Kelvin Y.K. Chan and has published in prestigious journals such as Nature, The Lancet and Analytical Biochemistry.

In The Last Decade

M. Mitchard

53 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Mitchard United Kingdom 17 287 150 149 142 117 57 884
W Theobald Switzerland 16 255 0.9× 166 1.1× 114 0.8× 171 1.2× 92 0.8× 47 872
Robert L. Wolen United States 15 362 1.3× 181 1.2× 94 0.6× 127 0.9× 92 0.8× 37 1.0k
J Heykants Belgium 20 229 0.8× 249 1.7× 135 0.9× 207 1.5× 153 1.3× 37 1.3k
G.J. Krol United States 18 398 1.4× 135 0.9× 148 1.0× 190 1.3× 152 1.3× 37 1.1k
Richard H. Reuning United States 15 133 0.5× 107 0.7× 143 1.0× 146 1.0× 124 1.1× 45 809
Ermelinda Sakmar United States 18 148 0.5× 171 1.1× 141 0.9× 103 0.7× 121 1.0× 40 909
Thomas M. Twomey United States 16 269 0.9× 146 1.0× 178 1.2× 182 1.3× 61 0.5× 20 730
Gilles Caillé Canada 20 357 1.2× 210 1.4× 275 1.8× 135 1.0× 146 1.2× 73 1.1k
C M Kaye United Kingdom 17 279 1.0× 156 1.0× 178 1.2× 92 0.6× 95 0.8× 43 997
C. A. M. van Ginneken Netherlands 21 507 1.8× 177 1.2× 123 0.8× 236 1.7× 98 0.8× 79 1.2k

Countries citing papers authored by M. Mitchard

Since Specialization
Citations

This map shows the geographic impact of M. Mitchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mitchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mitchard more than expected).

Fields of papers citing papers by M. Mitchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mitchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mitchard. The network helps show where M. Mitchard may publish in the future.

Co-authorship network of co-authors of M. Mitchard

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mitchard. A scholar is included among the top collaborators of M. Mitchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mitchard. M. Mitchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Margaret, M. J. Kendall, & M. Mitchard. (2008). Single dose and steady state pharmacokinetic study on methaqualone. Journal of Clinical Pharmacy and Therapeutics. 1(2). 63–68.
2.
Mitchard, M.. (1988). SULPHUR COMPOUNDS USED IN MEDICINE. Drug metabolism and drug interactions. 6(3-4). 183–202. 12 indexed citations
3.
Mitchard, M., et al.. (1987). Ranitidine drug interactions—a literature review. Pharmacology & Therapeutics. 32(3). 293–325. 28 indexed citations
4.
Evans, M E, et al.. (1979). Bioavailability of chlorpropamide.. British Journal of Clinical Pharmacology. 7(1). 101–105. 4 indexed citations
5.
Yates, R. A., M. Mitchard, & R. Wise. (1978). Disposition studies with amikacin after rapid intravenous and intramuscular administration to human volunteers. Journal of Antimicrobial Chemotherapy. 4(4). 335–341. 12 indexed citations
6.
Bianchetti, G., M. Mitchard, & P.L. Morselli. (1978). Quantitative determination of tiflorex in human fluids using electron-capture detection. Journal of Chromatography A. 152(1). 87–95. 2 indexed citations
7.
Rovei, V., et al.. (1978). PHARMACOKINETICS AND METABOLISM OF DILTIAZEM IN MAN. Abstracts. 35(1). 650–650. 64 indexed citations
8.
Harvey, Peter, et al.. (1977). The influence of alcohol on the persistent effects on human performance of the hypnotics Mandrax and Nitrazepam.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(8). 350–5. 10 indexed citations
9.
Mitchard, M., J. Andrews, M. J. Kendall, & Robert A. Wise. (1977). Mecillinam serum levels following intravenous injection: a comparison with pivmecillinam. Journal of Antimicrobial Chemotherapy. 3(suppl B). 83–88. 14 indexed citations
10.
Mitchard, M., et al.. (1976). Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.. BMJ. 2(6039). 794–795. 37 indexed citations
11.
Andrews, J., M. J. Kendall, & M. Mitchard. (1976). FACTORS INFLUENCING THE ABSORPTION AND DISPOSITION OF MECILLINAM AND PIVMECILLINAM IN MAN. British Journal of Clinical Pharmacology. 3(4). 627–632. 10 indexed citations
12.
Kendall, M. J. & M. Mitchard. (1976). BIOAVAILABILITY OF β‐ADRENOCEPTOR BLOCKING DRUGS. British Journal of Clinical Pharmacology. 3(6). 1066–1066. 1 indexed citations
13.
West, MJ, M. J. Kendall, M. Mitchard, & E. B. Faragher. (1976). A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects.. British Journal of Clinical Pharmacology. 3(3). 439–443. 26 indexed citations
14.
Williams, Margaret, et al.. (1974). THE INFLUENCE OF DIPHENHYDRAMINE ON THE ABSORPTION OF METHAQUALONE IN MAN. British Journal of Clinical Pharmacology. 1(3). 259–264. 4 indexed citations
15.
Williams, Margaret, et al.. (1974). AVAILABILITY OF METHAQUALONE FROM COMMERCIAL PREPARATIONS: in vitro AND in vivo STUDIES IN MAN. British Journal of Clinical Pharmacology. 1(2). 99–105. 6 indexed citations
16.
Finch, J, M. J. Kendall, & M. Mitchard. (1974). AN ASSESSMENT OF GASTRIC EMPTYING BY BREATHALYSER. British Journal of Clinical Pharmacology. 1(3). 233–236. 23 indexed citations
17.
Davis, S.S. & M. Mitchard. (1972). Development of New Drug Dosage Form. BMJ. 1(5799). 569.3–569. 1 indexed citations
18.
Mitchard, M.. (1972). Isomeric substrate studies with normal and atypical serum cholinesterase. Journal of Pharmacy and Pharmacology. 24(4). 328–329. 1 indexed citations
19.
Older, Paul, John Harris, & M. Mitchard. (1966). RESPIRATORY DEPRESSION FOLLOWING THE USE OF TACRINE AND SUXAMETHONIUM. British Journal of Anaesthesia. 38(6). 487–489. 1 indexed citations
20.
CLITHEROW, J. W., M. Mitchard, & N. Harper. (1963). The Possible Biological Function of Pseudo-cholinesterase. Nature. 199(4897). 1000–1001. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026